Effects of lipid delivery on insulin resistance in muscle
Official title: Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids
Run by Mayo Clinic · NCT03818178 · Data updated 2026-11-12
This study is testing how different types of fats affect insulin resistance in the muscles of healthy adults to see if it can help us understand issues related to Type 2 diabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | December 1, 2018 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT03818178 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy, non-obese adults aged 18-65 with a BMI between 18 and 27.
✕Probably not a fit
Patients with ischemic heart disease, atherosclerotic valvular disease, or those on medications that alter lipid profiles may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how the delivery of different types of lipids affects insulin resistance in muscle tissue among healthy, non-obese adults. Participants will receive either an overnight infusion of palm oil or Intralipid, with a saline control, to assess how these lipids influence fatty acid trafficking and insulin signaling. The study aims to clarify the role of intramyocellular fatty acids in muscle insulin resistance, which is a key factor in conditions like Type 2 diabetes. By measuring changes in muscle fat storage and glucose disposal rates, the research seeks to provide insights into metabolic health.
Why it matters
Potential benefit: If successful, this study could lead to new strategies for managing insulin resistance and improving metabolic health in patients.
How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that lipid profiles can significantly impact insulin sensitivity.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women and Men (Women premenopausal) * BMI 18-27 * Weight stable * Not pregnant/nursing Exclusion Criteria: * Ischemic heart disease * Atherosclerotic valvular disease * Smokers (\> 20 cigarettes per week) * Bilateral oophorectomy * Concomitant use of medications that can alter serum lipid profile (high dose fish oil, statins, niacin, fibrates, thiazolinediones, beta-blockers, atypical antipsychotics) * Lidocaine allergy
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Michael D Jensen, MD — Mayo Clinic
- Study coordinator: Pamela Reich
- Email: Reich.Pamela@mayo.edu
- Phone: 507-255-6062
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.